Development of Common Variable Immunodeficiency in an 8-year-old Boy Treated with Rituximab for Idio...
Development of Common Variable Immunodeficiency in an 8-year-old Boy Treated with Rituximab for Idiopathic Thrombocytopenia
About this item
Full title
Author / Creator
Publisher
Mary Ann Liebert, Inc. publishers
Journal title
Language
English
Formats
Publication information
Publisher
Mary Ann Liebert, Inc. publishers
Subjects
More information
Scope and Contents
Contents
We present the case of an 8-year-old boy who developed common variable immunodeficiency (CVID) following rituximab therapy for the treatment of idiopathic thrombocytopenia (ITP). Since rituximab can cause prolonged hypogammaglobulinemia and increased susceptibility to infections, monitoring of immunoglobulin levels, antibody responses, B cells, and...
Alternative Titles
Full title
Development of Common Variable Immunodeficiency in an 8-year-old Boy Treated with Rituximab for Idiopathic Thrombocytopenia
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_gale_infotracmisc_A187496602
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracmisc_A187496602
Other Identifiers
ISSN
0883-1874
E-ISSN
1557-7767
DOI
10.1089/pai.2008.0003
